Gamma Stimulation Promotes Amyloid Clearance @LifespanIO
Gamma Stimulation Promotes Amyloid Clearance  @LifespanIO
Uploaded April 2024 | Updated November 2026, 4 days ago
This Journal Club is on a paper demonstrating that noninvasive 40 Hz stimulation promotes 40 Hz neural activity in multiple brain regions and attenuates pathology in mouse models of Alzheimer’s disease. This is a subject close to our heart, as Dr. Medvedik and Lifespan.io are working on developing the Mindset project. This project aims to target Alzheimer’s disease using a headset that stimulates the brain with light and sound in order to trigger neural entrainment, thus reducing the loss of functional connectivity, combating brain atrophy, and improving cognitive function.

HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Make a one-time donation and learn about other ways to support us here: lifespan.io/support
► Learn more, and help us #CrowdsourceTheCure: lifespan.io
► Subscribe: youtube.com/user/LifespanIO
Gamma Stimulation Promotes Amyloid ClearanceEmerging Models of Biotech InvestmentFrom Physics To Aging Research -  Dr. Andrew Steele  - The Future Of Anti-aging BiotechnologyRegulatory Breakthroughs for Longevity and Blockchain Technology: Panel Discussion at EARD 2023Dr  Brad Stanfield on the Aging Interventions Currently AvailableRejuvenation Roundup Podcast - September 2021Digital Biomarkers and Games to Accelerate Geroscience | Keith Comito at Longevity Biomarker SummitVitaDAO - Decentralised Longevity Research - Tyler Golato | Lifespan.IOAging Clocks and Epigenetic Noise as Biomarker for Aging - Dr. Irina Conboy |  LRI Journal ClubJoin the Movement for Longevity with Lifespan.ioMichael Lustgarten on Optimizing Biologic Age - EARD 2022The BioAge Platform: From biomarkers to drug trials and back again: Eric Morgen, M.D. at EARD 2023
Lifespan Research Institute |

Gamma Stimulation Promotes Amyloid Clearance

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER